Form D · Pharmaceuticals

SMSA GAINESVILLE ACQUISITION CORP.

Plano, TX · CIK 0001474266

Offering snapshot reported Apr 15, 2014 · SEC filing

Reported sold
$30K
Offering amount: $5.38M
Investors reported
6
Form D · investor count
Minimum accepted
$5K
Reported outside-investor minimum
First sale
Apr 3, 2014
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$15K$30KMar 25, 2014: $20,000.00Mar 25, 2014Apr 15, 2014: $30,000.00Apr 15, 2014

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$20,000 → $30,000
  • Reported investors4 → 6

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Apr 15, 2014Amendment$30,000$10,000vs Mar 25, 20146SEC filing
Mar 25, 2014Initial$20,000No comparison4SEC filing

Offering details

Securities
Equity, Option to acquire, Security to be acquired
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-214164

Source: Form D, filed Apr 15, 2014. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Robert E Ham Executive
Kamran Nezami Director
Maulik Parikh Executive

Issuer details

Industry: Pharmaceuticals (See others in industry)

Address:
610 Coit Road Suite 200
Plano, TX, 75075